Doug Hampton

BoomerangFX Partners with DrFirst to Launch E-Prescribing for Aesthetic Medicine Practices Across North America

by

Partnership delivers first fully integrated solution that allows physicians to prescribe and manage patients’ medications while simultaneously utilizing Charting, EMR, Scheduling, Lead Management, CRM, Point-of-Sale Payments, Inventory Management and Accounting Reports. TORONTO and MIAMI, June 7, 2023 /PRNewswire/ – BoomerangFX, an international cloud-based SaaS provider of end-to-end practice management solutions for non-insured, private-pay healthcare segments … Read more

Expanding Role of Outsourcing Partners and Rising Demand for Full-Service Providers

by

DUBLIN, June 7, 2023 /PRNewswire/ — The “Medical Device Outsourcing: Global Strategic Business Report” report has been added to  ResearchAndMarkets.com’s offering. Global Medical Device Outsourcing Market to Reach $212.1 Billion by 2030 In the changed post COVID-19 business landscape, the global market for Medical Device Outsourcing estimated at US$105.2 Billion in the year 2022, is … Read more

MemorialCare Long Beach Medical Center’s Family Medicine Residency Program Celebrates 50th Anniversary

by

Training the next generation of physicians brings new clinical pathways, ideas, and collaboration to shape the future of healthcare in the greater Long Beach community. LONG BEACH, Calif., June 7, 2023 /PRNewswire/ — The Family Medicine Residency Program at MemorialCare Long Beach Medical Center and Miller Children’s & Women’s Hospital Long Beach is celebrating its … Read more

U.S. Immunology Treaters Resistant to Switching Stable Humira Patients to Biosimilars, According to Spherix Global Insights

by

Adalimumab biosimilars hold potential to grow the overall biologic-treated population, but only if the cost savings translate to patients and practices. EXTON, Pa., June 7, 2023 /PRNewswire/ — Amgen launched the first U.S. adalimumab biosimilar, Amjevita, in January 2023. Yet according to the latest findings from Spherix Global Insights, even the first to market advantage can’t … Read more

FibroScan® now recommended in primary care settings, according to Landmark Guidance from NICE

by

NICE recommends Echosens’ liver diagnostic solution for assessment of liver fibrosis and cirrhosis PARIS and WALTHAM, Mass., June 7, 2023 /PRNewswire/ — Most people don’t show symptoms of liver disease until it has progressed to an advanced stage, at which point no treatments are available. To help expel this reality, the National Institute for Health … Read more

$10 Million in Violence Prevention Grants Awarded to Communities Statewide from the Wisconsin Community Safety Fund

by

MILWAUKEE, June 7, 2023 /PRNewswire/ — The Comprehensive Injury Center at the Medical College of Wisconsin (MCW) has announced the 10 communities and organizations receiving $10.4 million in grant funding from the Wisconsin Community Safety Fund (WCSF) to aid in reducing violence stemming from the COVID-19 pandemic. The WCSF was created to support evidence-based activities … Read more

UPSTREAM’S PILLARS WITH PURPOSE AWARDS $13,500 TO NONPROFITS ASSISTING WITH MISSISSIPPI TORNADO RECOVERY

by

Upstream operates more than 50 physical therapy clinics in the state AMORY, Miss., June 7, 2023 /PRNewswire/ — The charitable arm of Upstream Rehabilitation, the nation’s largest outpatient physical therapy provider, has donated $13,500 to three nonprofits that assisted with this spring’s tornado recovery efforts in Mississippi. Upstream operates more than 50 clinics in Mississippi … Read more

H/K/B Cosmetic Surgery Acquires Lowcountry Plastic Surgery Center

by

CHARLOTTE, N.C., June 5, 2023 /PRNewswire/ — Charlotte, North Carolina based Kortesis Bharti Management Group, LLC, parent company to the rapidly expanding H/K/B Cosmetic Surgery brand, proudly announces the acquisition of Lowcountry Plastic Surgery Center in Mount Pleasant, SC. Lowcountry Plastic Surgery Center will now be known as H/K/B Mount Pleasant. Dr. Bill Kortesis and … Read more

SciTech Development Raises $2.73 Million in Oversubscribed Financing Round to Advance Clinical Trials for Cancer Treatment

by

— Financing Provides for the Advancement of Clinical Trials – GROSSE POINTE FARMS, Mich., June 7, 2023 /PRNewswire/ — SciTech Development today announced it has closed a $2.73M funding round, led by several prominent life science investors to advance clinical trials for Non-Hodgkin Lymphoma and Small Cell Lung Cancer.  SciTech’s capital investment is led by life science investors … Read more

Delcath Systems Announces Sandra Pennell as Senior Vice President of Finance

by

NEW YORK, June 7, 2023 /PRNewswire/ — Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased to announce that the Company has appointed Sandra Pennell as its new Senior Vice President of Finance. Ms. Pennell will also serve … Read more